Skip to content

LifeMD, Inc. LFMD Depreciation

Depreciation at other companies

Cencora logo
CencoraCOR
$142.3M+15.1%
DocGo logo
DocGoDCGO
PTH
Pelthos Therapeutics Inc.PTHS

Other financials

Income statement

See full
Revenue$50.2M-1.4%
Gross profit$44.2M+3.5%
Operating income-$8.9M-656%
Net income-$8.9M-4,728%
EPS (diluted)-$0.20-900%

Balance sheet

See full
Cash & equivalents$34.5M+7.9%
Total debt$6.2M-76.9%
Total equity$15.0M+746%
Total assets$70.1M-4.7%

Cash flow

See full
Operating cash flow$444.6K-85.5%
CapEx$105.2K-10.5%
Free cash flow$339.4K-88.5%

Valuation

See full
Market cap$235.53M-61.7%
Enterprise value$207.22M-66.2%
P/E41.6×
P/S1.3×-2.3×

Profitability

See full
Gross margin86.1%+0.9pp
Operating margin-9.8%-0.9pp
Net margin3.1%+1.8pp
FCF margin10.4%+1.7pp

Returns & leverage

See full
Return on equity-393.6%
Debt / equity0.4×
Current ratio+0.2×

Where this comes from

Reported directly by LifeMD, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: LifeMD, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LifeMD, Inc.'s depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LifeMD, Inc.'s depreciation?
LifeMD, Inc. (LFMD) reported depreciation of $289.46K in Q1 2026.
How has LifeMD, Inc.'s depreciation changed year-over-year?
LifeMD, Inc.'s depreciation increased by 86.3% year-over-year, from $155.36K to $289.46K.
What is the long-term trend for LifeMD, Inc.'s depreciation?
Over 3 years (2022 to 2025), LifeMD, Inc.'s depreciation has grown at a 74.9% compound annual growth rate (CAGR), from $161.89K to $865.52K.